3

PRIMARY DOCUMENT

Company: Protagenic Therapeutics, Inc.\new
Filed: August 9, 2005
Period of Report: August 9, 2005
Accession Number: 0001335468-05-000001

View Document ↗ View on SEC.gov ↗